Chandra Bhagat Pharma Complete Financial Statements
CBPL • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Chandra Bhagat Pharma (CBPL).
Downloads include all available records across all periods.
For market performance, see the
CBPL stock price today
.
Profitability Ratios
Net Profit Margin
1.09%
2025 data
EBITDA Margin
4.35%
2025 data
Operating Margin
-2.00%
2025 data
Return on Assets
0.98%
2025 data
Return on Equity
3.33%
2025 data
Balance Sheet Ratios
Current Ratio
49.00
2025 data
Debt to Equity
3.40
2025 data
Equity Ratio
29.41%
2025 data
Asset Turnover
0.90
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Equity Growth
+3.4%
Year-over-Year
Operating Cash Flow Growth
-200.0%
Year-over-Year
Investing Cash Flow Growth
+50.0%
Year-over-Year
Financing Cash Flow Growth
+133.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 92 | 233 | 120 | 96 | 71 | 94 | 107 |
| Expenses | 0 | 88 | 228 | 116 | 91 | 67 | 91 | 102 |
| EBITDA | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Operating Profit Margin % | 0.00% | -2.00% | -3.00% | 3.00% | 3.00% | 5.00% | 3.00% | 4.00% |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 2 | 1 | 2 | 3 | 4 | 3 | 4 |
| Profit Before Tax | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| Tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| Earnings Per Share (₹) | 0.00 | 1.14 | 2.03 | 1.20 | 1.06 | 0.25 | 0.55 | 13.38 |
Related Pages for Chandra Bhagat Pharma
Additional stock information and data for CBPL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 102 | 102 | 61 | 73 | 72 | 75 | 83 |
| Current Assets | 98 | 98 | 58 | 71 | 70 | 73 | 81 |
| Fixed Assets | 3 | 3 | 1 | 1 | 0 | 0 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 4 |
| Other Assets | 99 | 99 | 60 | 72 | 71 | 74 | 78 |
| LIABILITIES | |||||||
| Total Liabilities | 102 | 102 | 61 | 73 | 72 | 75 | 83 |
| Current Liabilities | 2 | 2 | 6 | 8 | 13 | 15 | 16 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 30 | 29 | 28 | 27 | 26 | 26 | 14 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 1 |
| Reserves & Surplus | 22 | 22 | 20 | 19 | 18 | 18 | 14 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -6 | 6 | 5 | 12 | 8 | -7 | 4 | -6 | -9 | 0 | 0 |
| Investing Activities | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 2 | -6 | -4 | -10 | -6 | 7 | -4 | 7 | 8 | 0 | 0 |
| Net Cash Flow | -5 | -2 | 1 | 3 | 2 | 0 | 0 | 0 | -1 | 0 | 0 |